Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XEN-D0501 add-on to metformin in type 2 diabetes mellitus
2018-001880-22Phase 2Completed
- Sponsor
- Pila Pharma
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing XEN-D0501 + metformin with Placebo + metformin (2 arms). Primary endpoint: Fasting blood glucose after four weeks of bi-daily dosing of XEN-D0501. Started Jul 2018; status: completed.
02
Drugs
XEN-D0501
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2018-001880-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001880-22.